Heritage Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Heritage Wealth Advisors's VRTX Position: Q3 2026 in Review
Heritage Wealth Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 38 shares — an estimated $18.9K sold.
Heritage Wealth Advisors first reported a position in VRTX in Q4 2019 and held it in 9 quarters. The position peaked at $25.7K in Q1 2025. 1,786 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Heritage Wealth Advisors reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Heritage Wealth Advisors sold 38 Vertex Pharmaceuticals shares in Q3 2026, an estimated $18.9K.
- Heritage Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q4 2019 and held it in 9 quarters.
- Heritage Wealth Advisors's Vertex Pharmaceuticals position peaked at $25.7K in Q1 2025.
- 1,786 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Heritage Wealth Advisors's 13F filing for Q3 2026, filed 9 Nov 2026.